Company: PCRX
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001396814-25-000061
Chunk: 36

Company: Pacira BioSciences, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 36
---
Item 1. FINANCIAL STATEMENTS (Unaudited)

PACIRA BIOSCIENCES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS 

(In thousands, except share and per share amounts)

(Unaudited)March 31,2025December 31,2024ASSETSCurrent assets:       Cash and cash equivalents$283,610 $276,774      Short-term available-for-sale investments210,016 207,841      Accounts receivable, net104,745 113,304      Inventories, net133,754 125,282      Prepaid expenses and other current assets27,837 21,929           Total current assets759,962 745,130 Fixed assets, net164,451 167,169 Right-of-use assets, net48,728 49,222 Goodwill21,520 — Intangible assets, net434,969 425,970 Deferred tax assets129,008 130,376 Investments and other assets28,031 35,649           Total assets$1,586,669 $1,553,516 LIABILITIES AND STOCKHOLDERS’ EQUITY  Current liabilities:       Accounts payable$23,172 $19,133      Accrued expenses80,069 80,124      Lease liabilities9,405 8,887      Current portion of convertible senior notes, net202,086 201,776           Total current liabilities314,732 309,920 Convertible senior notes, net279,801 279,334 Long-term debt, net101,489 104,211 Lease liabilities43,678 44,645 Contingent consideration17,566 20,241 Deferred tax liabilities6,996 — Other liabilities23,866 16,817           Total liabilities788,128 775,168 Commitments and contingencies (Note 16)Stockholders’ equity:  Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at March 31, 2025 and December 31, 2024— — Common stock, par value $0.001; 250,000,000 shares authorized; 47,120,647 shares issued and 46,283,